A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections

Conditions

• Infection

Interventions

• DRUG: Magnex (Sulbactam Sodium/Cefoperazone Sodium 1:1) Pfizer Ltd.
• DRUG: Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
• DRUG: Metrogyl (Metronidazole Injection IP) J.B.Chemicals & Pharmaceuticals Ltd.
• DRUG: Mikacin (Amikacin Sulphate Injection IP) Aristo Pharmaceuticals Ltd.

Sponsor

Pfizer